- ES
- EN
14th National Research Competition in Life and Earth Sciences
Rare diseases
Senior Researcher : Montserrat Milà Recasens
Research Centre or Institution : Fundació Clínic per a la Recerca Biomèdica. Hospital Clínic. Barcelona
The study of mental retardation is one of the most complex fields of human genetics due to its very high heterogeneity, and, although it affects between 1% and 3% of the general population, there is a scarce number of individuals with the same causation, which significantly hinders genetic studies.
On the other hand, genetic foundations are enormously complex and are, in turn, influenced by different environmental causes. In recent years, the application of high-resolution technologies has enabled the identification of genetic alterations due to DNA copy number variations (CNVs). This has made it possible to identify microdeletions and microduplications as the cause of mental retardation. On the other hand, CNVs have been described which do not seem to be associated with clinical manifestations and the meaning of which is currently unknown.
In this study, we aim to characterise and compare the frequency and distribution of X chromosome CNVs in patients with X-related mental retardation in a control group. The identification and characterisation of these CNVs will make it possible to identify new causes of mental retardation and to carry out future comparative studies on the control group and other groups of patients affected by different genetic diseases.
Activities related
Projects related
News related
Publications related
International Symposium Understanding and reprogramming developmental visual disorders: from anophthalmia to cortical impairments Madrid, Thursday and Friday, 30 and 31 January 2020, 9:30 hours
Panel Discussion Mundo de las prótesis, los nuevos materiales, sus complicaciones y su futuro Madrid , Lunes, 8 de abril 2024. 17.00 horas
Session Situación actual de las Enfermedades Raras en España Madrid, Martes, 23 de abril de 2024, 10:00 horas


La Fundación Ramón Areces refuerza su compromiso con las enfermedades raras
Published on 04/23/2024